In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples